Analytical Similarity Assessment of MYL-1402O to Reference Bevacizumab.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on biological therapy"
DOI: 10.1080/14712598.2021.1973426
Abstract: BACKGROUND Bevacizumab (BEV) is a recombinant humanized monoclonal immunoglobulin G1 antibody that binds to vascular endothelial growth factor (VEGF)-A and acts as an antiangiogenic agent. It is approved for treatment of many cancer indications, including… read more here.
Keywords: bev; 1402o reference; analytical similarity; myl 1402o ... See more keywords